BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 14733838)

  • 21. Endothelial nitric oxide synthase gene therapy for erectile dysfunction.
    Bivalacqua TJ; Musicki B; Usta MF; Champion HC; Kadowitz PJ; Burnett AL; Hellstrom WJ
    Curr Pharm Des; 2005; 11(31):4059-67. PubMed ID: 16378511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy in the management of erectile dysfunction (ED): past, present, and future.
    Melman A; Davies KP
    ScientificWorldJournal; 2009 Aug; 9():846-54. PubMed ID: 20333343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of gene transfer technology to study the pathophysiology of erectile dysfunction.
    Bivalacqua TJ; Strong TD
    J Sex Med; 2008 Feb; 5(2):268-75. PubMed ID: 18237370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction.
    Christ GJ; Hodges S
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S41-55. PubMed ID: 16465183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The application of gene therapy to the treatment of erectile dysfunction.
    Christ GJ; Melman A
    Int J Impot Res; 1998 Jun; 10(2):111-2. PubMed ID: 9647947
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene and stem cell therapy in the treatment of erectile dysfunction and pulmonary hypertension; potential treatments for the common problem of endothelial dysfunction.
    Nossaman BD; Gur S; Kadowitz PJ
    Curr Gene Ther; 2007 Apr; 7(2):131-53. PubMed ID: 17430132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases.
    Hipp JD; Davies KP; Tar M; Valcic M; Knoll A; Melman A; Christ GJ
    BJU Int; 2007 Feb; 99(2):418-430. PubMed ID: 17313427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of angiogenic factors for therapy of erectile dysfunction: protein and DNA transfer of VEGF 165 into the rat penis.
    Burchardt M; Burchardt T; Anastasiadis AG; Buttyan R; de la Taille A; Shabsigh A; Frank J; Shabsigh R
    Urology; 2005 Sep; 66(3):665-70. PubMed ID: 16140112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function.
    Lombardi G; Mondaini N; Giubilei G; Macchiarella A; Lecconi F; Del Popolo G
    J Sex Med; 2008 Sep; 5(9):2135-40. PubMed ID: 18637993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene transfer for the therapy of erectile dysfunction: progress in the 21st century.
    Melman A
    Int J Impot Res; 2006; 18(1):19-25. PubMed ID: 16281045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regenerative medicine in andrology: tissue engineering and gene therapy as potential treatment options for penile deformations and erectile dysfunction].
    Schultheiss D; Jonas U
    Actas Urol Esp; 2006 Sep; 30(8):801-11. PubMed ID: 17078577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing in vivo gene transfer into mouse corpus cavernosum by use of surface electroporation.
    Song KM; Choi MJ; Kwon MH; Ghatak K; Park SH; Ryu DS; Ryu JK; Suh JK
    Korean J Urol; 2015 Mar; 56(3):197-204. PubMed ID: 25763123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational approaches to the treatment of benign urologic conditions in elderly women.
    Lee C; Chermansky CJ; Damaser MS
    Curr Opin Urol; 2016 Mar; 26(2):184-92. PubMed ID: 26814884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?
    Shimizu S; Tsounapi P; Shimizu T; Honda M; Inoue K; Dimitriadis F; Saito M
    Int J Urol; 2014 Sep; 21(9):856-64. PubMed ID: 24930630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erectile dysfunction.
    Shamloul R; Ghanem H
    Lancet; 2013 Jan; 381(9861):153-65. PubMed ID: 23040455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoblast therapy for stress urinary incontinence and bladder dysfunction.
    Yokoyama T; Huard J; Chancellor MB
    World J Urol; 2000 Feb; 18(1):56-61. PubMed ID: 10766045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of intracavernous delivery of adenovirus encoding Smad7 gene on erectile function in a mouse model of cavernous nerve injury.
    Song KM; Chung JS; Choi MJ; Jin HR; Yin GN; Kwon MH; Park JM; Kim WJ; Lee SJ; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2014 Jan; 11(1):51-63. PubMed ID: 24433558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell-based therapy for erectile dysfunction.
    Wu JH; Xia SJ
    Chin Med J (Engl); 2011 Nov; 124(22):3810-5. PubMed ID: 22340246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging tools for erectile dysfunction: a role for regenerative medicine.
    Hakim L; Van der Aa F; Bivalacqua TJ; Hedlund P; Albersen M
    Nat Rev Urol; 2012 Sep; 9(9):520-36. PubMed ID: 22824778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.